Ishihara M, Nishida Y, Kitano S, Kawai A, et al. A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma. Int J Cancer 2023;152:2554-2566.
PMID: 36727538